Key facts
- This page summarizes Andrew Offer's Form 4 filing for Sight Sciences, Inc. (SGHT).
- 5 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 19 Jul 2021, 20:17.
Andrew Offer - 19 Jul 2021 Form 4 Insider Report for Sight Sciences, Inc. (SGHT)
- Reporting relationship
- Director
- Issuer ticker
- SGHT
- Reported as of
- 19 Jul 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 19 Jul 2021, 20:17:09 UTC
- Prior SEC filing
- 14 Jul 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jeremy Hayden, Attorney-in-Fact for Andrew Offer
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Andrew Offer filed Form 4 for Sight Sciences, Inc. (SGHT) on 19 Jul 2021.
Change
- Previous filing in this sequence was filed on 14 Jul 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SGHT
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +3,162
- Change %
- Price
- Shares after
- 3,162
- Date
- 19 Jul 2021
- Ownership
- Direct
- Footnotes
- F1
SGHT
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +2,225,752
- Change %
- +1721%
- Price
- Shares after
- 2,355,062
- Date
- 19 Jul 2021
- Ownership
- See footnote
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SGHT
transaction
Derivative
Series C Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -1,581
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 19 Jul 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,162
- Exercise price
- Footnotes
- F1
SGHT
transaction
Derivative
Series A Redeemable Convertible Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -1,086,956
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 19 Jul 2021
- Ownership
- See footnote
- Underlying class
- Common Stock
- Underlying amount
- 2,173,912
- Exercise price
- Footnotes
- F1, F2
SGHT
transaction
Derivative
Series B Redeemable Convertible Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -25,920
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 19 Jul 2021
- Ownership
- See footnote
- Underlying class
- Common Stock
- Underlying amount
- 51,840
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering.
Footnote F2
These shares are held of record by Scientific Health Development II, Ltd. ("SHD II"). SHD Management, LLC is the manager of SHD II. The reporting person is the Chief Executive Officer of SHD Management, LLC and may be deemed to beneficially own the shares of common stock held by SHD II.